Dr. Terry Marie Banks, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 160 Wendolyn Trce, Fayetteville, GA 30215 Phone: 770-719-3318 |
Michael S Robinowitz, M.D. Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 770-719-7256 Fax: 770-719-7378 |
Mrs. Vanessa Laquetta Freeman, PA-C Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Dominique Ct, Fayetteville, GA 30214 Phone: 770-584-5046 |
News Archive
The New York Times details differences in states' ability to regulate rates as well as in premium costs. Meanwhile, the Associated Press reports on the savings that New Yorkers could experience.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
Mirixa Corporation, the leading provider of Medication Therapy Management (MTM) and other pharmacist-delivered patient care services for health plans, announces their integration with PrescribeWellness, the SaaS Company with a cloud-based platform that delivers efficient patient communications and other services to community pharmacists.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
The Institute of Medicine (IOM) on March 30th released its new report on the public health dimensions of the epilepsies, the first authoritative independent appraisal of epilepsy and its management in the United States.
› Verified 7 days ago